erectile dysfunction

Generic Viagra Could Save Patients MillionsBoth Pfizer and Teva have brought out generic versions of Viagra, a boon to the millions of men with erectile dysfunction.
Shock waves may change future of ED therapyIt’s hard to argue against an erectile dysfunction treatment that is potentially disease modifying, is noninvasive, and seems to do no harm. The treatment, low-intensity shock wave therapy, has yet to earn the FDA’s approval but is widely used in other countries. Early results from ongoing U.S. trials are promising.
Does shock wave therapy have a future in the treatment of ED?
URS and ED risk: Intriguing association
Study questions use of pre-op cultures to prevent prosthetic infectionIn this video, Dr. Nicholas Kavoussi sits down with Dr. Arthur L. Burnett, II, of the Urology Times Editorial Council to discuss his 2016 AUA presentation, "Preoperative urine cultures for prosthetic urological surgery: What is the evidence?"
Private parts: Is ‘scrotox’ next?
Basic Science Research: Trimodal therapy shows promise in oligometastatic PCaOther basic science research pearls include preliminary evidence from a porcine model suggesting botulinum toxin type A facilitates ureteral stone passage and the identification of two different microdeletions in the NELL1 gene on chromosome 11 in men with Peyronie's disease.
Future of ED treatment may lie in cell-based therapiesThe future of erectile dysfunction management following prostate cancer surgery will likely include novel options, among them cell-based therapies, North American experts in the field predict.
ED, diabetes, and CV risk: Update on treatment, risk reductionIn this article, we review the etiology and pathophysiology of ED in this challenging patient population and provide an approach to treatment and risk reduction via lifestyle modification and pharmacologic intervention.
Shock wave therapy found efficacious in treating EDExperience with low-intensity extracorporeal shock wave therapy from multinational clinical trials demonstrates it is a safe, effective, and well-tolerated treatment for erectile dysfunction, including in men who do not respond to an oral phosphodiesterase type-5 inhibitor, reported Robert Feldman, MD, at the AUA annual meeting in New Orleans.